Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06207032 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

StatusRecruiting
PhaseNot specified
SponsorTempus AI
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study arms: 6 to 7v15
  2. Study sites: 28 to 32v14
  3. Study sites: 26 to 28v13
  4. Study sites: 24 to 26v12
  5. Site details revised at 23 of 24 sites Study arms: 3 to 6v11 Show 1 more changeShow less
    • Study arms: 3 to 6
Show 9 earlier versionsHide 9 earlier versions
  1. Study sites: 21 to 24v10
  2. Study sites: 20 to 21v9
  3. Study sites: 18 to 20v8
  4. Study sites: 15 to 18v7
  5. Study sites: 8 to 15v6
  6. Study sites: 4 to 8 Start date changed from estimate of Jun 1, 2024 to Jun 26, 2024v5 Show 1 more changeShow less
    • Start date changed from estimate of Jun 1, 2024 to Jun 26, 2024
  7. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 4 · Study arms: 1 to 3v4 Show 2 more changesShow less
    • Study sites: 0 to 4
    • Study arms: 1 to 3
  8. Re-verified, no change to tracked fieldsv3
  9. Primary endpoint revised Secondary endpoint revisedv2 Show 1 more changeShow less
    • Secondary endpoint revised

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Tempus AI
13 trials monitored
See all monitored trials
This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.
Trial Details
NCT Number NCT06207032
Lead Sponsor Tempus AI
Conditions Cancer
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov